These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 30685233)

  • 1. A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation.
    Liu Y; Cheng Y; Wen Y; Li C; Chen G; Li M
    BMC Nephrol; 2024 Mar; 25(1):87. PubMed ID: 38448817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.
    Qin Y; Sun XJ; Hu YF; Jing M; Yu XJ; Zhao MH; Tan Y
    Ren Fail; 2024 Dec; 46(1):2332491. PubMed ID: 38584145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report.
    Kato J; Okonogi H; Kanzaki G; Katsumata H; Nakada Y; Sagasaki M; Komine K; Ito K; Saito T; Matsunaga A; Tokutou K; Honda K; Tsuboi N; Yokoo T
    BMC Nephrol; 2024 May; 25(1):171. PubMed ID: 38769490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein glomerulopathy: a rare cause of steroid-resistant nephrotic syndrome in a child.
    Vala K; Shah K; Kapadia S; Khandelwal M; Jojera A; Soni S; Prajapati A; Saha A
    CEN Case Rep; 2024 Mar; ():. PubMed ID: 38438730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first case of lipoprotein glomerulopathy complicated with collagen type III glomerulopathy and literature review.
    Liu H; Luo C; Li Z; Zhang C; Xiong J
    J Nephrol; 2023 Apr; 36(3):663-667. PubMed ID: 36370330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein Glomerulopathy With Complete Resolution With Fenofibrate: Report of First Case From Pakistan.
    Shaker N; Ben Musa R; Shaker N; Nasir H; Kamran TE; Poombal F; Abid A; Abu Shakra R; Mansoor I
    Int J Surg Pathol; 2024 Feb; ():10668969241228298. PubMed ID: 38327135
    [No Abstract]   [Full Text] [Related]  

  • 7. Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy.
    Katsarou M; Stratikos E; Chroni A
    J Lipid Res; 2018 Dec; 59(12):2339-2348. PubMed ID: 30309894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular lipidosis as a feature of renal-limited macrophage activation syndrome in a transplanted kidney: a case report.
    Sugisaki K; Uchida T; Iwama S; Okihara M; Akashi I; Kihara Y; Konno O; Kuroda M; Koike J; Iwamoto H; Oda T
    BMC Nephrol; 2023 Nov; 24(1):329. PubMed ID: 37936128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteinuria-hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome.
    Clement LC; Macé C; Del Nogal Avila M; Marshall CB; Chugh SS
    Transl Res; 2015 Apr; 165(4):499-504. PubMed ID: 25005737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.
    Yang M; Weng Q; Pan X; Hussain HMJ; Yu S; Xu J; Yu X; Liu Y; Jin Y; Zhang C; Li X; Ren H; Chen N; Xie J
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1281. PubMed ID: 32441489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E-related glomerular disorders.
    Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E
    Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
    Xie W; Xie Y; Lin Z; Xu X; Zhang Y
    Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
    Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J
    J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein Glomerulopathy, First Case Report from Canada.
    Ting JA; McRae SA; Schwartz D; Barbour SJ; Riazy M
    Int J Nephrol Renovasc Dis; 2022; 15():207-214. PubMed ID: 35761986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.
    Li MS; Li Y; Liu Y; Zhou XJ; Zhang H
    Front Med (Lausanne); 2022; 9():905007. PubMed ID: 35602473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: A Pediatric Case of Lipoprotein Glomerulopathy in China and Literature Review.
    Song Y; Yang C; Liu L; Wang H
    Front Pediatr; 2021; 9():684814. PubMed ID: 34513758
    [No Abstract]   [Full Text] [Related]  

  • 17. A young Chinese man with nephrotic syndrome due to lipoprotein glomerulopathy.
    Lui DTW; Lee ACH; Yap DYH; Chan GSW; Tan KCB
    J Clin Lipidol; 2019; 13(2):251-253. PubMed ID: 30685233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
    Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
    Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
    da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF
    Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.